The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells
Abstract
Share and Cite
Cerna, T.; Hrabeta, J.; Eckschlager, T.; Frei, E.; Schmeiser, H.H.; Arlt, V.M.; Stiborová, M. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells. Int. J. Mol. Sci. 2018, 19, 164. https://doi.org/10.3390/ijms19010164
Cerna T, Hrabeta J, Eckschlager T, Frei E, Schmeiser HH, Arlt VM, Stiborová M. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells. International Journal of Molecular Sciences. 2018; 19(1):164. https://doi.org/10.3390/ijms19010164
Chicago/Turabian StyleCerna, Tereza, Jan Hrabeta, Tomas Eckschlager, Eva Frei, Heinz H. Schmeiser, Volker M. Arlt, and Marie Stiborová. 2018. "The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells" International Journal of Molecular Sciences 19, no. 1: 164. https://doi.org/10.3390/ijms19010164
APA StyleCerna, T., Hrabeta, J., Eckschlager, T., Frei, E., Schmeiser, H. H., Arlt, V. M., & Stiborová, M. (2018). The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells. International Journal of Molecular Sciences, 19(1), 164. https://doi.org/10.3390/ijms19010164

